Shigematsu Works Co., Ltd. (TYO:7980)
Japan
· Delayed Price · Currency is JPY 998.00
-5.00 (-0.50%)
Mar 10, 2026, 9:35 AM JST
Shigematsu Works Revenue
Shigematsu Works had revenue of 4.05B JPY in the quarter ending December 31, 2025, with 17.92% growth. This brings the company's revenue in the last twelve months to 14.87B, up 6.70% year-over-year. In the fiscal year ending March 31, 2025, Shigematsu Works had annual revenue of 14.11B with 8.60% growth.
Revenue (ttm)
14.87B
Revenue Growth
+6.70%
P/S Ratio
0.48
Revenue / Employee
38.12M
Employees
390
Market Cap
7.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 14.11B | 1.12B | 8.60% |
| Mar 31, 2024 | 13.00B | 120.00M | 0.93% |
| Mar 31, 2023 | 12.88B | 957.00M | 8.03% |
| Mar 31, 2022 | 11.92B | -781.00M | -6.15% |
| Mar 31, 2021 | 12.70B | 1.10B | 9.50% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ASO International | 3.95B |
| KAINOS Laboratories | 4.44B |
| JMS Co.,Ltd. | 66.09B |
| Daiken Medical | 10.17B |
| JTEC Corporation | 2.01B |
| SEED Co.,Ltd. | 33.57B |
| Medius Holdings | 295.20B |
| Sincere Co., LTD. | 7.46B |